{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:32:33Z","timestamp":1790058753746,"version":"4.0.1"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-15-1037","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T22:07:25Z","timestamp":1450735645000},"page":"395-403","source":"Crossref","is-referenced-by-count":19,"title":["Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients\u3000\u2013 Annual Intravascular Ultrasound Evaluation \u2013"],"prefix":"10.1253","volume":"80","author":[{"given":"Takuma","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Seguchi","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yanase","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Hisamatsu","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Sunami","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihide","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. <i>Eur Heart J<\/i> 2012; 33: 1787\u20131847.","DOI":"10.1093\/eurheartj\/ehs104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report: 2013; focus theme: Age. <i>J Heart Lung Transplant<\/i> 2013; 32: 951\u2013964.","DOI":"10.1016\/j.healun.2013.08.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakatani T, Fukushima N, Ono M, Saiki Y, Matsuda H, Yozu R, et al. The registry report of heart transplantation in Japan (1999\u20132013). <i>Circ J<\/i> 2014; 78: 2604\u20132609.","DOI":"10.1253\/circj.CJ-14-0970"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, et al. Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab. <i>Circ J<\/i> 2015; 79: 368\u2013374.","DOI":"10.1253\/circj.CJ-14-0718"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. <i>J Heart Lung Transplant<\/i> 2010; 29: 717\u2013727.","DOI":"10.1016\/j.healun.2010.05.017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schmauss D, Weis M. Cardiac allograft vasculopathy: Recent developments. <i>Circulation<\/i> 2008; 117: 2131\u20132141.","DOI":"10.1161\/CIRCULATIONAHA.107.711911"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Anderson TJ, Meredith IT, Uehata A, Mudge GH, Selwyn AP, Ganz P, et al. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation. <i>Circulation<\/i> 1993; 88: 1093\u20131100.","DOI":"10.1161\/01.CIR.88.3.1093"},{"key":"8","unstructured":"8. Yeung AC, Davis SF, Hauptman PJ, Kobashigawa JA, Miller LW, Valantine HA, et al. Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound <i>J Heart Lung Transplant<\/i> 1995; 14: S215\u2013S220."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: Outcomes after five years. <i>J Am Coll Cardiol<\/i> 2005; 45: 1532\u20131537.","DOI":"10.1016\/j.jacc.2005.02.035"},{"key":"10","unstructured":"10. Mehra MR, Ventura HO, Stapleton DD, Smart FW. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: A paradigm shift. <i>J Heart Lung Transplant<\/i> 1995; 14: S207\u2013S211."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. <i>J Am Coll Cardiol<\/i> 2005; 45: 1538\u20131542.","DOI":"10.1016\/j.jacc.2004.12.076"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vassalli G, Gallino A, Weis M, von Scheidt W, Kappenberger L, von Segesser LK, et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. <i>Eur Heart J<\/i> 2003; 24: 1180\u20131188.","DOI":"10.1016\/S0195-668X(03)00237-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Caforio AL, Tona F, Fortina AB, Angelini A, Piaserico S, Gambino A, et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: Multivariate risk factor analysis and role of immunosuppression. <i>Am J Transplant<\/i> 2004; 4: 962\u2013970.","DOI":"10.1111\/j.1600-6143.2004.00434.x"},{"key":"14","unstructured":"14. Johnson MR. Transplant coronary disease: Nonimmunologic risk factors. <i>J Heart Lung Transplant<\/i> 1992; 11: S124\u2013S132."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mehra MR, Ventura HO, Chambers R, Collins TJ, Ramee SR, Kates MA, et al. Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study. <i>J Am Coll Cardiol<\/i> 1995; 26: 1537\u20131544.","DOI":"10.1016\/0735-1097(95)00357-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Braga JR, Santos IS, McDonald M, Shah PS, Ross HJ. Factors associated with the development of cardiac allograft vasculopathy: A systematic review of observational studies. <i>Clin Transplant<\/i> 2012; 26: E111\u2013E124.","DOI":"10.1111\/j.1399-0012.2011.01565.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. <i>J Heart Lung Transplant<\/i> 2005; 24: 1710\u20131720.","DOI":"10.1016\/j.healun.2005.03.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. <i>J Heart Lung Transplant<\/i> 2013; 32: 1147\u20131162.","DOI":"10.1016\/j.healun.2013.08.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakatani T. Heart transplantation. <i>Circ J<\/i> 2009; 73(Suppl A): A55\u2013A60.","DOI":"10.1253\/circj.CJ-09-0340"},{"key":"20","unstructured":"20. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group: The International Society for Heart Transplantation. <i>J Heart Transplant<\/i> 1990; 9: 587\u2013593."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. St. Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stinson EB, Billingham ME, et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. <i>Circulation<\/i> 1992; 86: 756\u2013763.","DOI":"10.1161\/01.CIR.86.3.756"},{"key":"22","unstructured":"22. Mehra MR, Ventura HO, Stapleton DD, Smart FW, Collins TC, Ramee SR. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. <i>J Heart Lung Transplant<\/i> 1995; 14: 632\u2013639."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Seguchi O, Fujita T, Murata Y, Sunami H, Sato T, Watanabe T, et al. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: A single-center experience in Japan. <i>Heart Vessels<\/i>2015 February 15, doi:10.1007\/s00380-015-0649-1.","DOI":"10.1007\/s00380-015-0649-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Konig A, Kilian E, Rieber J, Schiele TM, Leibig M, Sohn HY, et al. Assessment of early atherosclerosis in de novo heart transplant recipients: Analysis with intravascular ultrasound-derived radiofrequency analysis. <i>J Heart Lung Transplant<\/i> 2008; 27: 26\u201330.","DOI":"10.1016\/j.healun.2007.10.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Potena L, Masetti M, Sabatino M, Bacchi-Reggiani ML, Pece V, Prestinenzi P, et al. Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation. <i>J Heart Lung Transplant<\/i> 2015; 34: 1146\u20131153.","DOI":"10.1016\/j.healun.2015.01.990"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nagji AS, Hranjec T, Swenson BR, Kern JA, Bergin JD, Jones DR, et al. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: Implications for donor allocation. <i>Ann Thorac Surg<\/i> 2010; 90: 168\u2013175.","DOI":"10.1016\/j.athoracsur.2010.03.043"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lietz K, John R, Mancini DM, Edwards NM. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; implications for donor selection criteria. <i>J Am Coll Cardiol<\/i> 2004; 43: 1553\u20131561.","DOI":"10.1016\/j.jacc.2004.02.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Forster CS, Argenziano M, et al. Effect of donor age on long-term survival following cardiac transplantation. <i>J Card Surg<\/i> 2006; 21: 125\u2013129.","DOI":"10.1111\/j.1540-8191.2006.00189.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Weiss ES, Nwakanma LU, Patel ND, Yuh DD. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: An analysis of the UNOS database. <i>J Heart Lung Transplant<\/i> 2008; 27: 184\u2013191.","DOI":"10.1016\/j.healun.2007.11.566"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: Current concepts. <i>Am Heart J<\/i> 1995; 129: 791\u2013799.","DOI":"10.1016\/0002-8703(95)90331-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. <i>Cardiovasc Res<\/i> 2009; 83: 247\u2013261.","DOI":"10.1093\/cvr\/cvp033"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kobayashi Y, Fukushima N, Ohtake S, Sawa Y, Nishimura M, Matsumiya G, et al. The effect of donor age in graft coronary atherosclerosis after cardiac transplantation. <i>Transplant Proc<\/i> 2002; 34: 2587\u20132588.","DOI":"10.1016\/S0041-1345(02)03435-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kobashigawa JA, Pauly DF, Starling RC, Eisen H, Ross H, Wang SS, et al. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: Substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial. <i>JACC Heart Fail<\/i> 2013; 1: 389\u2013399.","DOI":"10.1016\/j.jchf.2013.07.002"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Stoica SC, Cafferty F, Pauriah M, Taylor CJ, Sharples LD, Wallwork J, et al. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. <i>J Heart Lung Transplant<\/i> 2006; 25: 420\u2013425.","DOI":"10.1016\/j.healun.2005.11.449"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, et al. Cellular rejection and rate of progression of transplant vasculopathy: A 3-year serial intravascular ultrasound study. <i>J Heart Lung Transplant<\/i> 2001; 20: 393\u2013398.","DOI":"10.1016\/S1053-2498(00)00249-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. <i>Circ Res<\/i> 2006; 99: 801\u2013815.","DOI":"10.1161\/01.RES.0000246086.93555.f3"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. <i>Circulation<\/i> 1987; 76: 827\u2013834.","DOI":"10.1161\/01.CIR.76.4.827"},{"key":"38","unstructured":"38. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: Time for a reappraisal. <i>J Heart Lung Transplant<\/i> 1997; 16: 743\u2013751."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, et al. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. <i>J Heart Lung Transplant<\/i> 2009; 28: 320\u2013327.","DOI":"10.1016\/j.healun.2009.01.006"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-1037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T02:14:20Z","timestamp":1498270460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/2\/80_CJ-15-1037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-1037","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}